Anticoagulant Citrate Dextrose A ACD-A
Active substance: CITRIC ACID MONOHYDRATE, SODIUM CITRATE, UNSPECIFIED FORM, DEXTROSE MONOHYDRATE
INJECTION, SOLUTION · CITRIC ACID MONOHYDRATE .08 g/10mL, SODIUM CITRATE, UNSPECIFIED FORM .22 g/10mL, DEXTROSE MONOHYDRATE .245 g/10mL
United StatesActive
Marketing holder: Arteriocyte Medical Systems, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- CITRIC ACID MONOHYDRATE · .08 g/10mL
- SODIUM CITRATE, UNSPECIFIED FORM · .22 g/10mL
- DEXTROSE MONOHYDRATE · .245 g/10mL
Products containing citric acid in other countries
Showing products with this active substance, combinations included; the full composition is shown for each product.
| Country | Products |
|---|---|
| RU 15 |
|
Registration
- Registration number
- 43203-852
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- EXTRACORPOREAL
Sources
- product · openFDA NDC · 43203-852 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 43203-852 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 43203-852 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 43203-852 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 43203-852 · Verified 2026-10-09 · open in source